RFTN1
Raftlin
Also known as: FLJ23866, KIAA0084, MIG2, Raftlin, RFTN1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14699
- Gene
- RFTN1
- Ensembl
- ENSG00000131378
- Chromosome
- 3
- Canonical length
- 578 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables double-stranded RNA binding activity. Involved in B cell receptor signaling pathway; membrane raft assembly; and positive regulation of growth rate. Acts upstream of or within dsRNA transport; response to exogenous dsRNA; and toll-like receptor 3 signaling pathway. Located in endosome; membrane raft; and plasma membrane. Part of protein-containing complex. Biomarker of glaucoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
578 residues, UniProt reviewed canonical sequence.
>Q14699|RFTN1
1 MGCGLNKLEK RDEKRPGNIY STLKRPQVET KIDVSYEYRF LEFTTLSAAE LPGSSAVRLA
61 SLRDLPAQLL ELYQQGFSLA ALHPFVQPTH EREKTPLEHI FRAILIKKTD RSQKTDLHNE
121 GYILELDCCS SLDHPTDQKL IPEFIKKIQE AASQGLKFVG VIPQYHSSVN SAGSSAPVST
181 ANSTEDARDA KNARGDHASL ENEKPGTGDV CSAPAGRNQS PEPSSGPRGE VPLAKQPSSP
241 SGEGDGGELS PQGVSKTLDG PESNPLEVHE EPLSGKMEIF TLFNKPKSHQ KCRQYYPVTI
301 PLHVSKNGQT VSGLDANWLE HMSDHFRKGG MLVNAVFYLG IVNDSLHGLT DGVFIFEAVS
361 TEDSKTIQGY DAIVVEQWTV LEGVEVQTDY VPLLNSLAAY GWQLTCVLPT PVVKTTSEGS
421 VSTKQIVFLQ RPCLPQKIKK KESKFQWRFS REEMHNRQMR KSKGKLSARD KQQAEENEKN
481 LEDQSSKAGD MGNCVSGQQQ EGGVSEEMKG PVQEDKGEQL SPGGLLCGVG VEGEAVQNGP
541 ASHSRALVGI CTGHSNPGED ARDGDAEEVR ELGTVEENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RFTN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 110 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 110 nTPM
- lymph node: 109 nTPM
- thymus: 68 nTPM
- blood vessel: 64 nTPM
- adipose tissue: 54 nTPM
- thyroid gland: 50 nTPM
Single-cell type
- pdcs: 351 nCPM
- cdc: 294 nCPM
- nk-cells: 267 nCPM
- t-cells: 232 nCPM
- adipocytes: 215 nCPM
- fibro-adipogenic progenitors: 198 nCPM
Immune cell
- non-classical monocyte: 82 nTPM
- NK-cell: 80 nTPM
- T-reg: 61 nTPM
- basophil: 56 nTPM
- intermediate monocyte: 46 nTPM
- total PBMC: 38 nTPM
Brain region
- cerebral cortex: 32 nTPM
- medulla oblongata: 30 nTPM
- hypothalamus: 28 nTPM
- basal ganglia: 23 nTPM
- white matter: 20 nTPM
- hippocampal formation: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell receptor signaling pathway
- dsRNA transport
- membrane raft assembly
- positive regulation of growth rate
- positive regulation of interleukin-17 production
- protein localization to membrane raft
- protein transport into membrane raft
- response to exogenous dsRNA
- T cell antigen processing and presentation
- T cell receptor signaling pathway
- toll-like receptor 3 signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RFTN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RFTN1 as an antibody target. Whether an autoantibody or antibody against RFTN1 could matter depends on whether native RFTN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RFTN1 is annotated at the cell surface, where native RFTN1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RFTN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...